Taxifolin Inhibits the Growth of Non-Small-Cell Lung Cancer via Downregulating Genes Displaying Novel and Robust Associations with Immune Evasion Factors

SIMPLE SUMMARY: Lung cancer (LC) is the leading cause of cancer deaths. While the current immunotherapies are beneficial to patients, the effects are minimal and heterogeneous, which calls for improvements in patient selection and treatment effectiveness. We discovered taxifolin to inhibit LC. The i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Xiaozeng, Dong, Ying, Gu, Yan, Wei, Fengxiang, Peng, Jingyi, Su, Yingying, Wang, Yanjun, Yang, Chengzhi, Neira, Sandra Vega, Kapoor, Anil, Tang, Damu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571863/
https://www.ncbi.nlm.nih.gov/pubmed/37835514
http://dx.doi.org/10.3390/cancers15194818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571863/
https://www.ncbi.nlm.nih.gov/pubmed/37835514
http://dx.doi.org/10.3390/cancers15194818

Ejemplares similares